These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4080707)

  • 1. Effects of cholecystokinin and vasoactive intestinal peptide on locomotion and rearing in neofrontal decorticated rats.
    Katsuura G; Itoh S
    Prog Clin Biol Res; 1985; 192():147-50. PubMed ID: 4080707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral effects of cholecystokinin and its related peptides in rats.
    Itoh S; Katsuura G
    Prog Clin Biol Res; 1985; 192():139-45. PubMed ID: 2934743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversed behavioral effect of cholecystokinin after frontal decortication in rats.
    Itoh S; Katsuura G; Itoh T; Morimoto T
    Life Sci; 1994; 55(11):PL213-6. PubMed ID: 8072383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermotility induced by vasoactive intestinal peptide in the rat: its reciprocal action to cholecystokinin octapeptide.
    Itoh S; Katsuura G; Yoshikawa K
    Peptides; 1985; 6(1):53-7. PubMed ID: 3991364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
    Crawley JH
    Prog Clin Biol Res; 1985; 192():131-8. PubMed ID: 4080706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of octapeptide of cholecystokinin, vasoactive intestinal peptide and substance P on dynamics of biliary system and cardiovascular system.
    Zou S; Zhang J; Qiu F
    Chin Med J (Engl); 1998 Dec; 111(12):1071-4. PubMed ID: 11263366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interaction of octapeptide of cholecystokinin, vasoactive intestinal peptide and substance P on dynamics of biliary system and cardiovascular system].
    Zhang J; Zou S; Qiu F
    Zhonghua Wai Ke Za Zhi; 1997 Jan; 35(1):48-51. PubMed ID: 10374510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The regulatory effect of VIP on exploratory behavior of the rat and on the neuromediator level in the normal brain and in frontal lobectomy].
    Romanova GA; Karganov MIu
    Fiziol Zh SSSR Im I M Sechenova; 1989 May; 75(5):670-6. PubMed ID: 2569988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of vasoactive intestinal polypeptide and cholecystokinin octapeptide on the control of gallbladder contraction.
    Strah KM; Melendez RL; Pappas TN; Debas HT
    Surgery; 1986 Apr; 99(4):469-73. PubMed ID: 3952671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effect of cholecystokinin octapeptide in vagotomized rats.
    Itoh S; Katsuura G
    Can J Physiol Pharmacol; 1986 Jun; 64(6):745-7. PubMed ID: 3756626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sulfated cholecystokinin octapeptide and cholecystokinin tetrapeptide in rat behavior after blockade of nitric oxide synthase by L-NAME.
    Hoły Z; Wiśniewski K
    Rocz Akad Med Bialymst; 1998; 43():250-70. PubMed ID: 9972062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal peptide and PHI stimulate somatostatin release from rat cerebral cortical and diencephalic cells in dispersed cell culture.
    Tapia-Arancibia L; Reichlin S
    Brain Res; 1985 Jun; 336(1):67-72. PubMed ID: 2860951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cholecystokinin octapeptide and vasoactive intestinal polypeptide on adrenocortical secretion in the rat.
    Itoh S; Hirota R; Katsuura G
    Jpn J Physiol; 1982; 32(4):553-60. PubMed ID: 6294390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretagogue-induced membrane alterations in dispersed acini from rat pancreas.
    Adler G; Kern HF; Pan GZ; Gardner JD
    Eur J Cell Biol; 1984 Mar; 33(2):234-41. PubMed ID: 6325191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal polypeptide (VIP) inhibits potassium-induced release of cholecystokinin (CCK) from rat caudato-putamen but not from cerebral cortex.
    Allard LR; Beinfeld MC
    Neuropeptides; 1986 Oct; 8(3):287-93. PubMed ID: 3785588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of vasoactive intestinal peptide, somatostatin, neurotensin, cholecystokinin octapeptide, and secretin on intestinal absorption of amino acid in rat.
    Chen YF; Feng ZT; Wen SH; Lu GJ
    Dig Dis Sci; 1987 Oct; 32(10):1125-9. PubMed ID: 2888609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of cholecystokinin with vasoactive intestinal peptide in body shaking response to ice-water immersion in rats.
    Katsuura G; Yoshikawa K; Itoh S
    Neurosci Lett; 1983 Oct; 40(3):299-302. PubMed ID: 6646503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide in cirrhotic rats: hemodynamic effects and mesenteric arterial receptor characteristics.
    Lee SS; Huang M; Ma Z; Rorstad O
    Hepatology; 1996 May; 23(5):1174-80. PubMed ID: 8621151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VIP suppression in the intestine and cerebral cortex following administration of VIP antiserum to newborn rats.
    Díaz-Juárez JL; Frechilla D; Romero G; Sánchez-Franco F; Del Río J
    Rev Esp Fisiol; 1994 Jun; 50(2):109-15. PubMed ID: 7800913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Excitatory effects of 2 peptides on rat cortical neurons: laminar distribution and correlation with the effect of acetylcholine].
    Dutar P; Lamour Y; Jobert A
    C R Seances Acad Sci III; 1982 Sep; 295(3):247-50. PubMed ID: 6817863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.